The store will not work correctly when cookies are disabled.
8-chloro-9-(3-methoxypyridin-4-yl)-2-methyl-[1,2,4]triazolo[1,5-c]quinazolin-5(6H)-one
ID: ALA4874818
PubChem CID: 164627620
Max Phase: Preclinical
Molecular Formula: C16H12ClN5O2
Molecular Weight: 341.76
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cnccc1-c1cc2c(cc1Cl)[nH]c(=O)n1nc(C)nc21
Standard InChI: InChI=1S/C16H12ClN5O2/c1-8-19-15-11-5-10(9-3-4-18-7-14(9)24-2)12(17)6-13(11)20-16(23)22(15)21-8/h3-7H,1-2H3,(H,20,23)
Standard InChI Key: GUHXFWYBLHWPTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
19.5121 -18.9192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5110 -19.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2190 -20.1477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2172 -18.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9259 -18.9156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9247 -19.7408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6348 -20.1521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3506 -19.7428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0572 -20.1534 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6347 -18.5013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3481 -18.8557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9056 -18.2866 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5367 -17.5805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7513 -17.7133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9002 -16.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8064 -18.5109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8075 -17.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1006 -17.2843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3920 -17.6931 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3948 -18.5145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1023 -18.9192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8029 -20.1468 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.5156 -17.2846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2229 -17.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 11 1 0
8 9 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 2 0
13 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
1 16 1 0
2 22 1 0
17 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 341.76 | Molecular Weight (Monoisotopic): 341.0680 | AlogP: 2.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 85.17 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.73 | CX Basic pKa: 4.80 | CX LogP: 2.92 | CX LogD: 2.92 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.61 | Np Likeness Score: -1.12 |
References
1. Rietz TA, Teuscher KB, Mills JJ, Gogliotti RD, Lepovitz LT, Scaggs WR, Yoshida K, Luong K, Lee T, Fesik SW.. (2021) Fragment-Based Discovery of Small Molecules Bound to T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (TIM-3)., 64 (19.0): [PMID:34597046] [10.1021/acs.jmedchem.1c01336] |